Endpoints News· Max Gelman·· 1 小时前AI 评分22
分析师在关键性数据读出前追问 Biogen 狼疮药物 litifilimab
Analysts press Biogen on lupus drug litifilimab ahead of pivotal readouts
AI 导读
在多项对 CEO Chris Viehbacher 转型计划至关重要的 Phase 3 数据读出前，分析师对 Biogen 后期管线、尤其是狼疮药物 litifilimab 提出大量追问。
正文 · 原文
Scrutiny of Biogen’s late-stage pipeline is intensifying ahead of several Phase 3 readouts that are pivotal to CEO Chris Viehbacher’s turnaround efforts.
Analysts lobbed numerous …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news